Cystic fibrosis and International normalised ratio increased

Summary:

International normalised ratio increased is found among people with Cystic fibrosis, especially for people who are female, 10-19 old.

The study analyzes which people have International normalised ratio increased with Cystic fibrosis. It is created by eHealthMe based on reports of 23 people who have Cystic fibrosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Cystic fibrosis?

Cystic fibrosis (disease of the secretary glands) is found to be associated with 256 drugs and 49 conditions by eHealthMe. Check the latest studies of Cystic fibrosis.

What is International normalised ratio increased?

International normalised ratio increased is found to be associated with 1,340 drugs and 1,726 conditions by eHealthMe. Check the latest studies of International normalised ratio increased.

On Jul, 08, 2026

23 people who have Cystic Fibrosis and International Normalised Ratio Increased are studied.

Would you have International normalised ratio increased when you have Cystic fibrosis?

Gender of people who have Cystic Fibrosis and experienced International Normalised Ratio Increased *:

female: 60.87 %
male: 39.13 %

Age of people who have Cystic Fibrosis and experienced International Normalised Ratio Increased *:

Common co-existing conditions for these people *:

Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 5 people, 21.74%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 3 people, 13.04%
Sinus Disorder (disease of sinus): 2 people, 8.70%
Constipation: 2 people, 8.70%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 8.70%
Dyspnea (difficult or laboured breathing): 2 people, 8.70%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 4.35%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 1 person, 4.35%
Birth Control: 1 person, 4.35%
Bronchopulmonary Aspergillosis Allergic (allergic lung disorder caused by aspergillus fungi): 1 person, 4.35%

Common drugs taken by these people *:

Common symptoms for these people *:

Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 7 people, 30.43%
Pneumonia: 5 people, 21.74%
Blood Urea Increased: 5 people, 21.74%
Weight Increased: 3 people, 13.04%
Fatigue (feeling of tiredness): 3 people, 13.04%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 13.04%
Weight Decreased: 3 people, 13.04%
Abdominal Pain: 3 people, 13.04%
Vaginal Bleeding: 3 people, 13.04%
Thrombocytopenia (decrease of platelets in blood): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have International normalised ratio increased?

- Check whether International normalised ratio increased is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Cystic fibrosis (51,820 reports)
International normalised ratio increased (40,071 reports)

All the drugs that are associated with International normalised ratio increased:

International normalised ratio increased (1,340 drugs)

All the conditions that are associated with International normalised ratio increased:

International normalised ratio increased (1,726 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on International normalised ratio increased and Cystic fibrosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.